BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)
4,370.00
-5.00 (-0.11%)
Sep 19, 2025, 3:30 PM KST
BCWORLD PHARM. Revenue
BCWORLD PHARM. had revenue of 20.44B KRW in the quarter ending June 30, 2025, with 5.05% growth. This brings the company's revenue in the last twelve months to 75.32B, up 3.23% year-over-year. In the year 2024, BCWORLD PHARM. had annual revenue of 74.81B, down -0.39%.
Revenue (ttm)
75.32B
Revenue Growth
+3.23%
P/S Ratio
0.49
Revenue / Employee
268.99M
Employees
280
Market Cap
36.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 74.81B | -296.36M | -0.39% |
Dec 31, 2023 | 75.11B | 2.41B | 3.31% |
Dec 31, 2022 | 72.70B | 10.62B | 17.11% |
Dec 31, 2021 | 62.08B | 5.05B | 8.85% |
Dec 31, 2020 | 57.03B | 5.53B | 10.74% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |